High performance of the BCR/ABL-extra sensitive (ES) probe for detection of der(9q) deletion in t(9;22) (q34;q11.2)

被引：5

作者：

Najfeld, V ^{[1
]}

机构：

[1] Mt Sinai Med Ctr, New York, NY 10029 USA

来源：

CANCER GENETICS AND CYTOGENETICS | 2002年 / 132卷 / 02期

关键词：

D O I：

10.1016/S0165-4608(01)00554-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：171 / 171

页数：1

共 4 条

[1] Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene:: expression profiling, resistance to interferon therapy, and poor prognosis [J].

Cohen, N ;

Rozenfeld-Granot, G ;

Hardan, I ;

Brok-Simoni, F ;

Amariglio, N ;

Rechavi, G ;

Trakhtenbrot, L .

CANCER GENETICS AND CYTOGENETICS, 2001, 128 (02) :114-119

[2] Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals [J].

Mohr, B ;

Bornhäuser, M ;

Platzbecker, U ;

Freiberg-Richter, J ;

Naumann, R ;

Prange-Krex, G ;

Mohm, J ;

Kroschinsky, F ;

Ehninger, G ;

Thiede, C .

CANCER GENETICS AND CYTOGENETICS, 2001, 127 (02) :111-117

[3] Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia [J].

Sinclair, PB ;

Nacheva, EP ;

Leversha, M ;

Telford, N ;

Chang, J ;

Reid, A ;

Bench, A ;

Champion, K ;

Huntly, B ;

Green, AR .

BLOOD, 2000, 95 (03) :738-744

[4] Improved sensitivity of BCR-ABL detection: A triple-probe three-color fluorescence in situ hybridization system [J].

Sinclair, PB ;

Green, AR ;

Grace, C ;

Nacheva, EP .

BLOOD, 1997, 90 (04) :1395-1402

← 1 →